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Abstract Epidemiological studies from Sub-Saharan Africa
indicate that allergies are on the rise in this region especially in
urban compared to rural areas. This increase has been linked
to improved hygiene, lifestyle changes, and lower exposure to
pathogens in childhood. Reduced exposure to parasitic worm
(helminth) infections and allergy outcomes has been the focus
of a number of population studies over the years. Paradoxically,
there are parallels in the immune responses to helminths and to
allergies. Both conditions are associated with elevated levels of
immunoglobulin E, high numbers of T helper 2 cells, eosino-
phils, and mast cells. These immune parallels have meant that
the diagnosis of allergies in parts of the world where helminths
are endemic can be hampered. The aim of this review is to
examine observations from population studies conducted in
Sub-Saharan Africa that demonstrate how helminth infections
influence the parameters used to diagnose allergy outcomes in
this region. We explore specifically how helminth infections
hinder the in vitro diagnosis of allergic sensitization, influence
the clinical manifestations of allergy, and also the effect of
anthelmintic treatment on allergy outcomes. Advancing our
understanding of how helminths influence allergy diagnosis is
imperative for the development of improved tools to assess,
diagnose, and treat allergic disorders in both helminth-
endemic and non-endemic countries worldwide.
Keywords Allergy diagnosis . Allergic inflammation .
Helminths . IgE cross-reactivity . Immune
hyporesponsiveness . Sub-Saharan Africa
Introduction
Time trends indicate a sharp rise in the incidence of allergic
disease worldwide especially among children [1]. This in-
crease has also been seen in Sub-Saharan Africa [2, 3] where
several population studies have observed a higher prevalence
of allergic disease among urban compared to rural individuals
[3–9]. Within these countries, improved hygiene, reduced
pathogenic exposure during childhood, and the adoption of a
so-called “western lifestyle” are all factors that explain this
rise [10]. Of particular interest, in tropical areas of the world,
is the relationship between exposure to parasitic worm
(helminth) infections and allergic disease (Table 1).
Helminth infections remain highly prevalent in tropical
areas with over 1.5 billion people worldwide thought to be
chronically infected with at least one soil-transmitted helminth
[21]. Moreover, an estimated 240 million individuals, mostly
residing in Sub-Saharan Africa, are affected by the waterborne
helminth disease schistosomiasis [22].
Despite the lack of geographical overlap in areas of the
world with the highest burden of helminth infection and places
most affected by allergic disease, strong parallels exist be-
tween these two conditions on the immunological level.
Both are associated with the induction of strong T helper 2
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Table 1 Studies linking helminth infections to allergic disease diagnosis in Sub-Saharan Africa
Mechanism Helminth species Observation Reference
Helminth-induced IgE
cross-reactivity and
allergic sensitization
diagnosis
Helminth species
not specified
Elevated levels of IgE were observed to the oligosaccharide
associated with delayed mammalian meat reactions,
galactose-α-1,3-galactose (α-gal) among
rural and urban Kenyans from areas where
helminths were endemic. No direct link
was made between α-gal sensitization and specific
helminth species.
Commins et al. 2011 [11]
Helminth species
not specified
Raised levels of IgE to α-gal among Zimbabweans
from a helminth-endemic rural area. Strong
correlations were also observed between levels
of IgE to α-gal and IgE to cat allergens Fel d
5 and cat dander extract. No direct link was
made between α-gal and specific helminth species.
Arkestål et al. 2011 [12]
Ascaris
lumbricoides
Positive association found between specific
IgE to Ascaris antigen and skin prick test reactivity
to aeroallergens among urban adolescents in South
Africa. Observed association could be explained by
IgE cross-reactivity between Ascaris proteins and
corresponding homologues in house dust mite and cockroach.
Levin et al. 2012 [13]
Schistosoma
haematobium
High levels of IgE to peanut extract among children
in Ghana that did not translate into peanut skin prick
test reactivity or peanut allergy symptoms. These
levels were strongly associated with S. haematobium
infection as well as correlated with IgE to cross-reactive
carbohydrate determinants (CCDs).
Amoah et al. 2013 [14•]
Helminth-induced
allergic inflammation
Anisakis spp Bronchial hyper-reactivity and dermatitis in fish-processing
workers in South Africa linked to exposure to Anisakis spp.
Nieuwenhuizen et al. 2006 [15]
A. lumbricoides Positive association observed between A. lumbricoides
infection and airway hyper-responsiveness in urban
and rural children in South Africa.
Calvert and Burney 2010 [7]
Onchocerca volvulus Pruritic skin disease simulating atopic dermatitis seen
among Ethiopian immigrants in Israel. Individuals
exhibiting skin condition found to be infected with
Onchocerca volvulus.
Baum et al. 2014 [16•]
A. lumbricoides Positive association established between A. lumbricoides
infection and reported wheeze in study participants greater
than 5 years of age living in fishing communities around
Lake Victoria in Uganda.
Webb et al. 2016 [17]
Effect of anthelmintic
treatment on allergy
outcome diagnosis
A. lumbricoides,
Trichuris trichiura
S. haematobium
Increased risk of skin prick test reactivity to house dust
mite extract seen in Gabonese children following
anthelmintic treatment for
S. haematobium and intestinal helminths.
Van den Biggelaar 2004 [18]
Hookworm
M. perstans
S. mansoni
Strongyloides stercoralis
T. trichiura
Treatment with albendazole for soil-transmitted
helminths among pregnant women in Uganda was found to
be strongly linked to a higher risk of doctor-diagnosed
infantile eczema and reported recurrent wheeze
in their offspring.
Praziquantel treatment for S. mansoni in infected
mothers was associated with a higher risk of
infantile eczema but not among infants whose
mothers were S. mansoni negative.
Mpairwe et al. 2011 [19•]
Hookworm
S. mansoni
Negative association between being positive for any
helminth infection and allergy outcomes in Ethiopian
immigrants in Israel. One year post-anthelmintic treatment,
an increase in allergy symptoms was observed in treated
individuals.
Stein et al. 2016 [20•]
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(Th2) immune responses leading to elevated levels of immu-
noglobulin E (IgE) as well as the presence of eosinophils, mast
cells, and Th2 cytokines [23, 24]. The immune parallels be-
tween these conditions have meant that the diagnosis of aller-
gy outcomes in regions of the world where helminths are
persistent can be hampered or result in unique clinical presen-
tations [25••].
In this review, findings from population studies conducted in
Sub-Saharan Africa that illustrate how helminth infections influ-
ence the parameters used to diagnose allergy outcomes are exam-
ined. We explore specifically how helminth infections hinder the
in vitro diagnosis of allergic sensitization and influence the clinical
manifestations of allergic disease.
Diagnosis of Allergy Outcomes
The clinical diagnosis of IgE-mediated allergy inmany countries is
based primarily on a physical examination, history of symptoms,
and the determination of allergic sensitization [26•]. Although less
common in Sub-Saharan Africa, in many high income countries,
food or drug challenges are additional tools routinely used in aller-
gy diagnosis [26•].
Allergic sensitization—the production of serum-specific IgE
against harmless antigens known as allergens—is a well-
established factor in the development of allergic disease [27] and
crucial to allergy diagnosis. The determination of allergic sensitiza-
tion isbasedon themeasurementof specific IgE toallergensaswell
as the assessment of skin reactivity to a panel of allergens.
In vitro assessment of allergic sensitization can be deter-
mined by the measurement of allergen-specific IgE by assays
such as an enzyme-linked immunosorbent assay (ELISA),
radioallergosorbent test (RAST), ImmunoCAP assay or more
recently, microarray allergen assay [28].
Skin prick testing is used to assess allergic sensitization to a panel
of environmental or food allergens as well as to negative and positive
controls. A skin prick test (SPT) involves applying an allergen in
liquid form to the skin of a patient, piercing the drop with a lancet
and determining whether a reaction occurs within 15 to 20 min fol-
lowing application [29]. If the SPT is positive,mast cell degranulation
will result in the formation of a wheal visible on the skin at the site of
the lancet prick. A mean wheal diameter of ≥3 mm is generally
accepted as a positive reaction and provides an indication of allergic
sensitization [29]. The prick-to-prick test is a variation of the
standard SPT in which a fresh allergen extract source such
as a fruit or vegetable is used [30]. In high-income countries,
a strong correlation is often observed between allergen-
specific IgE and SPT reactivity while in less developed coun-
tries, the presence of specific IgE does not always translate
into equivalent numbers of allergic skin reactions [10]. Over
the years, evidence from population studies in Sub-Saharan
Africa has shown how helminths influence the diagnosis of
allergy from in vitro testing to clinical presentation.
Helminth Infections and the Assessment of IgE
Sensitization
In the late 1960s, S.G.O. Johansson and colleagues published
one of the first studies linking the then newly characterized
IgE antibody to helminth infections. Their investigation found
that a group of pre-school children in Ethiopia had up to 20
times higher levels of total IgE compared to Swedish children
and that a sub-group of Ethiopian children infected with the
helminth Ascaris lumbricoides had 28 times higher levels of
total IgE [31•]. Even in this early study, Johansson et al. pos-
tulated that helminth infection may be an important factor in
stimulating the production of IgE in infected individuals [31•].
Subsequently, several investigations from Sub-Saharan
Africa have observed raised levels of allergen-specific IgE
related to helminth infection that did not translate into allergy
symptoms [14•, 32, 33]. This phenomenon can be attributed to
IgE cross-reactivity in which antibodies directed against one
epitope recognize similar epitopes in homologous molecules
[34, 35]. In the field of allergy, the allergen that induces the
initial allergic reaction is termed the “primary sensitizer” and
subsequent molecules are considered cross-reactive allergens
[34].
Since the early 1980s, two forms of cross-reactivity linked
to allergy have been described: cross-reactivity due to proteins
and cross-reactivity due to the sugar structures on glycopro-
teins known as cross-reactive carbohydrate determinants
(CCDs).
Cross-reactivity between plant-derived proteins is well-
characterized especially in relation to food allergy [36].
Although less described, cross-reactivity between inverte-
brate-derived allergens (such as from mite, cockroach, and
shrimp) with helminth antigens is an emergent field of interest
[37••, 38]. Several proteins found in helminths and other in-
vertebrates might play a role in IgE cross-reactivity such as
tropomyosin [35, 39–42], glutathione S-transferase (GST)
[43, 44], and paramyosin [45]. However, a structural and im-
munological investigation has shown that cross-reactivity
among homologous proteins, such as GSTs from Ascaris
and cockroach or mite, is not always significant [46].
Although a number of population studies from South
America have investigated IgE cross-reactivity between pro-
teins from helminths such as Ascaris lumbricoides and homo-
logues from house dust mite or cockroach, there are very few
studies in this area from Sub-Saharan Africa. However, pub-
lished literature provides indications that IgE cross-reactivity
between homologous proteins may explain some observations
made in studies from Africa over the years. For example, in
urban black adolescents in Cape Town, South Africa, a posi-
tive association was seen between specific IgE to Ascaris an-
tigen and SPT reactivity to aeroallergens (house dust mite and
cockroach) [13]. Although not explored, the positive SPTs in
that study could have been the result of IgE cross-reactivity
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between proteins from Ascaris such as tropomyosin or GST
and their corresponding homologues in house dust mite and
cockroach.
Aside from Ascaris, other helminths have been implicated
in IgE cross-reactivity involving proteins. For example, cross-
reactivity between the filarial nematode Onchocerca volvulus
tropomyosin (OvTrop) and house dust mite tropomyosin
(Der p 10) has been shown [40]. While this cross-reactivity
may explain elevated levels of specific IgE to house dust mite
seen in areas endemic for onchocerciasis (river blindness), it
has yet to be demonstrated in population studies.
Cross-reactive carbohydrate determinants (CCDs) on in-
sect and plant glycoproteins are carbohydrate components that
have been linked to IgE cross-reactivity [47]. The most char-
acterized N-glycan motifs associated with carbohydrate cross-
reactivity are an α-(1,3)-linked fucose on a proximal N-
acetylglucosamine and a β-(1,2)-linked xylose on a core man-
nose [48]. Aalberse and colleagues first reported IgE antibod-
ies directed against CCDs in 1981 [49]. A subsequent study
by the same group demonstrated that high levels of IgE
against peanut extract in a Dutch cohort of grass pollen-
allergic patients without symptoms of peanut allergy were
due to IgE against CCDs [50].
The role of helminths in carbohydrate cross-reactivity was
illustrated in an investigation in Ghana among 1604 school-
children in which raised levels of IgE against whole peanut
extract were observed that did not translate into peanut allergy
symptoms [14•]. In that study, 18% of participants were pea-
nut IgE-sensitized (Immunocap ≥ 0.35 kU/L), yet 92% were
SPT negative [14•]. Current S. haematobium infection was
also positively linked to peanut IgE sensitization as well as a
strong correlation seen between IgE to CCDs and IgE to
whole peanut extract. Inhibition assays in a subset of children
showed that S. haematobium soluble egg antigen and the CCD
marker bromelain were strong inhibitors of IgE binding to
peanut extract [14•]. IgE to CCDs hampers in vitro testing of
allergen-specific IgE through false positives and the blocking
of IgE to CCDs has been demonstrated to improve the detec-
tion of allergen-specific IgE [51].
Although IgE to CCDs is generally thought to be biologi-
cally inactive, the clinical relevance of IgE to some CCDs has
been reported in a study that found that about one third of
CCD-positive sera from individuals with tomato allergy had
biologically relevant CCD-specific IgE [52]. Moreover, IgE
against the mammalian carbohydrate epitope galactose-α-1,3-
galactose (α-gal) has been recently associated with two forms
of anaphylaxis [53]. Firstly, anaphylactic reactions to the first
infusion of the monoclonal antibody cetuximab among cancer
patients undergoing therapy in the Southeastern USA [54] and
the second being delayed onset reactions hours after the con-
sumption of mammalian meat products [55]. These reactions
have been seen in the Southeastern USA, Central America,
Australia, and East Asia [53]. IgE directed against α-gal is
thought to be induced by ticks and a strong correlation has
been observed between reported history of tick bites and ele-
vated levels of IgE to α-gal [56]. Although no direct link has
been made between α-gal and helminths in Africa, raised
levels of IgE to α-gal have also been seen in individuals from
helminth-endemic areas in Kenya [11] and Zimbabwe [12].
More investigations are necessary to determine the source of
α-gal sensitization in helminth-endemic areas in Sub-Saharan
Africa and whether specific helminths play a role in this
sensitization.
Component-Resolved Diagnostics and Improving Allergy
Diagnosis
IgE cross-reactivity between helminth antigens and environ-
mental or food allergens demonstrates the limited diagnostic
value of assessing IgE reactivity to whole allergen extracts in
populations from helminth-endemic areas. Whole extracts are
made up of multiple allergenic and non-allergenic compo-
nents which often lack standardization in their allergen con-
tent [57]. In recent years, the field of in vitro allergy diagnos-
tics has developed component resolved diagnostics (CRD) in
which IgE sensitization to individual allergen molecules is
assessed using purified natural and recombinant allergens
[58]. Advances in biochemistry and molecular biology have
facilitated the sequencing, synthesizing, and cloning of aller-
genic proteins which have all led to the production of recom-
binant allergens for CRD [59].
Among Ghanaian schoolchildren with elevated IgE to
whole peanut extract that was strongly associated with
S. haematobium infection, CRD in a subset showed that de-
spite these high levels, very low responses to recombinant
peanut allergens Ara h 1, 2, and 3 were seen [14]. Although
not related to helminths, Wollmann and colleagues used CRD
to investigate IgE reactivity to peanut allergen components
(Ara h 1–3, 6, 8, 9) among allergic patients in Zimbabwe
who were IgE-sensitized to whole peanut extract but had no
symptoms of peanut allergy [60]. While 46% of these
Zimbabwean patients had IgE to at least one of the highly
allergenic peanut components, half of this patient cohort had
elevated levels of IgE to CCDs [60]. Both these studies dem-
onstrate how CRD can be a useful tool in improving the spec-
ificity of in vitro allergy diagnosis in Sub-Saharan Africa.
Helminth Infections and Clinical Presentations
of Allergic Disorders
Helminth-Induced Allergic Inflammation
Research has shown that in some individuals who have low
exposure to helminths such as travelers or recent migrants
to a helminth-endemic area, robust inflammatory allergic
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responses can develop to helminths [61]. In addition, the
life-cycles of particular helminths, such as A. lumbricoides,
Strongyloides stercoralis, and hookworm, involve the mi-
gration of the larval stage through the lungs which may
result in respiratory symptoms often associated with asth-
ma such as wheeze and dyspnoea (shortness of breath)
[62•].
Th2-mediated responses to migrating larvae during hel-
minth infection provides one explanation for positive associ-
ations between A. lumbricoides infection and symptoms of
asthma such as wheeze seen in a number of population studies
in Sub-Saharan Africa. For example, in South Africa, an in-
vestigation found that A. lumbricoides infection among urban
and rural children was associated with increased odds of a
marker of airway hyperresponsiveness: exercise-induced
bronchoconstriction [7]. More recently, a household survey
of 2316 individuals conducted in fishing communities on
Lake Victoria in Uganda, observed a positive association be-
tween A. lumbricoides infection, and reported wheeze among
participants greater than 5 years of age [17]. It is important to
note, however, that aside from migrating larval stages, cross-
reactivity between helminth antigens such as tropomyosin or
GST may also explain positive associations between helminth
infection and symptoms of asthma as has been observed in
Colombia [41].
Migrating larvae are also a feature of other helminth infections
such as onchocerciasis where larvae known as microfilariae mi-
grate to the skin, eyes, and organs [63]. Onchocercal skin disease
is a clinical manifestation of immune responses to migrating
microfilariae in the skin during onchocerciasis [63]. Two major
forms of onchocercal skin disease exist: a mild form and a severe
form [64]. The mild form of onchocercal skin disease is associ-
ated with chronic Onchocerca volvulus infection, and in this
form,microfilariae induce a state of immune hyporesponsiveness
in the host which ensures the survival of the parasite through the
regulation of strong Th2 immune responses [64]. The more rare
but severe hyperreactive form of onchocercal skin disease is
characterized by severe skin inflammation and is associated with
strong Th17 and Th2 inflammatory responses as well as reduced
numbers of regulatory T cells [64]. In both forms of onchocercal
skin disease, the death of microfilariae under the skin, either
following chemotherapy or spontaneously, may induce a strong
inflammatory reaction in the host and the release of mediators of
the allergic immune response [61].
The effects of the reversal of immune hyporesponsiveness
associated with chronic onchocerciasis have been illustrated
by a small retrospective study of 27 Ethiopian immigrants in
Israel who presented with pruritic skin disease simulating
atopic dermatitis [16•]. In that study, half the patients with
pruritic skin disease were tested for Onchocerca volvus and
all those tested were found to be positive for onchocerciasis
based on serology for the marker of active disease IgG4 or
skin snip test [16•]. Interestingly, for 92% of these patients,
symptoms of pruritic skin disease started on average 2 years
following immigration to Israel. The authors noted that the
majority of their patients displayed the hyperreactive form of
onchocerciasis associated with low-level infections and strong
Th2 responses [16•]. They also hypothesized that changes in
exposure to environmental factors, resulting from migration
from a developing country to a high-income country, may
have triggered an immunological shift that played a role in
the onset of symptoms of onchocerciasis [16•].
Aside from migrating larval stages, transient helminth in-
fections where humans are not the definitive host like
Toxocara spp. can also induce Th2 inflammatory responses
in the airways or the skin [61]. This has been demonstrated in
Sub-Saharan Africa by research on infections with the marine
helminth Anisakis. Marine mammals are definitive hosts of
Anisakiswhile fish and cephalopods (octopuses/squids/cuttle-
fish) are intermediate hosts for its larval stages [15]. Humans
become accidental hosts of Anisakis by consumption of the
larval stage of the parasite in undercooked/raw fish or cepha-
lopods [65]. Symptoms of Anisakis infection can include
gastro-allergic reactions as well as anaphylaxis while expo-
sure through the respiratory tract or skin can result in anaphy-
laxis, rhinoconjunctivitis, asthma, and dermatitis [65].
Nieuwenhuizen et al. reported on bronchial hyperreactivity
and dermatitis in fish-processing workers in South Africa as
a result exposure to Anisakis [15]. Their investigation also
included an experimental murine model which was used to
demonstrate that the Anisakis infective larval stage (L3) in-
duced strong Th2 immune responses in mice. A later study by
the same group found that following epicutaneous exposure to
Anisakis antigens in mice, the Th2 cytokine interleukin (IL)-
13 played an important part in protein contact dermatitis while
another Th2 cytokine IL-4 was key in driving systemic ana-
phylaxis [66].
There are no other published studies on Anisakis infection
in humans in other parts of Sub-Saharan Africa. It is possible
that this is as a result of under-reporting as many cases of the
infection go undiagnosed [65].
Effect of Anthelmintic Treatment on Allergy Outcome
Diagnosis
Chronic helminth infections induce immune regulatory
networks in the host which are characterized by regulatory
T cells, regulatory B cells, and alternatively activated mac-
rophages [67]. An anti-inflammatory environment is the
end result and is typified by elevated levels of IL-10 and
TGF-β as well as general T cell hyporesponsiveness and
attenuation of responsiveness to so-called “bystander anti-
gens” that include vaccines and allergens [67]. Although
there have been inconsistencies in observations, a number
of population studies from Sub-Saharan Africa have ob-
served an inverse relationship between chronic helminth
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infections and allergy outcomes [33, 68–73]. Differences
in helminth species, timing, and intensity of infection as well
as host genetics all contribute to the variations observed in
population studies [61, 74].
Removal of helminths by chemotherapy can reverse im-
mune hyporesponsiveness to allergens associated with chron-
ic helminth infections. Although observations have varied,
several longitudinal studies conducted in helminth-endemic
areas worldwide have observed a positive association between
anthelmintic treatment and allergen skin reactivity [75–77].
However, some studies have also observed no effect of anthel-
mintic treatment [78], an effect on specific allergens only [79],
or a temporal effect [80].
In Gabon, a randomized, controlled trial was conducted in
which 317 children aged 5–13 years living in a helminth-
endemic area were given anthelmintic treatment (a combina-
tion of praziquantel for Schistosoma infection and meben-
dazole for intestinal helminths) or a placebo every 3 months
and skin prick tested every 6 months for a 30month follow-up
period [18]. In that study, anthelmintic treatment was associ-
ated with increased risk of SPT reactivity to house dust mite
extract (hazard ratio = 2.51; 95% CI, 1.85–3.41) and this in-
creased risk was found to be mediated partly by a reduction in
intestinal helminth infection (ascariasis and trichuriasis) [18].
The significance of early-life events and timing in the rela-
tionship between helminth infections and allergy outcomes
was demonstrated by a large randomized, double-blind,
placebo-controlled trial in Uganda. The trial established that
treatment with albendazole (compared with placebo) for soil
transmitted helminths among pregnant women was strongly
associated with an increased risk of doctor-diagnosed infantile
eczema in their children [19•]. Praziquantel treatment for
Schistosoma infection in infected mothers was linked to a
higher risk of doctor-diagnosed infantile eczema but had no
effect among infants whose mothers were S. mansoni negative
[19•]. The trial also found that albendazole treatment was
positively correlated with reported recurrent wheeze [19•].
Subsequently, children from this birth cohort were random-
ized to receive quarterly doses of anthelmintic treatment
(albendazole) from 15 months to 5 years [81]. By 5 years,
albendazole treatment had no effect on atopic eczema but this
is not unexpected given that helminth infection was low in this
birth cohort [81].
Recently, Stein and colleagues examined the burden of
helminth infections among 126 immigrants from Ethiopia
newly arrived in Israel and related these to allergy outcomes
[20•]. The most prevalent helminth infection detected was
hookworm (73.1%) followed by S. mansoni infection (47.2%)
[20•]. Among these newly arrived immigrants, a negative asso-
ciation was observed between any helminth infection and “al-
lergy” which was defined as the concomitant presence of pos-
itive SPT to common environmental allergens and clinical
symptoms allergy derived from a questionnaire [20•]. Less than
half of the study participants consented to take anthelmintic
treatment and 1 year later, a general increase in clinical allergy
symptoms and SPT reactivity was seen [20•]. Both chemother-
apy and the lack of exposure to helminths for re-infection are
likely to have contributed to an increase in allergy outcomes.
This study has implications for the diagnosis of clinical mani-
festations of allergy in both helminth-endemic and non-
endemic areas worldwide.
Future Perspectives
Studies from helminth-endemic areas in Sub-Saharan Africa
on IgE cross-reactivity between helminth antigens and aller-
gens have shown that the specificity and diagnostic accuracy
of in vitro testing of allergy can be greatly improved by the use
of recombinant allergens for the evaluation of IgE responses
to allergens. Future investigations in this region could greatly
benefit from the use of CRD.
Although allergy studies among Ethiopian immigrants in
Israel have had small sample sizes, they provide pertinent
examples of how changing environments due to interconti-
nental migration from a helminth-endemic region to a high
income country can lead to clinical manifestations of allergy
symptoms that are closely linked to helminth infections. With
more global migration and movement of people, such obser-
vations have implications for improving allergy diagnosis not
only in helminth-endemic areas but in other parts of the world.
Research from Sub-Saharan Africa has shown that novel
allergens exist that are relevant to this region, particularly in
relation to food allergy [82]. Additionally, the origins of sen-
sitization to some allergens that have been well-characterized
in other parts of the world remain unknown in Africa. For
example, among Ghanaian schoolchildren with elevated IgE
to peanut extract, high levels of biological active IgE to the
recombinant peanut allergen Ara h 9 were seen in a few indi-
viduals [14•]. Ara h 9 is a part of the non-specific lipid transfer
protein (LTP) allergen family and is known to be important in
peanut allergy in the Mediterranean region [83]. The source of
sensitization to LTPs in Ghana remains unknown and more
studies are needed to investigate whether helminth infections
play a role in inducing sensitization to this and other novel
allergens.
Understanding the relationship between helminth infec-
tions and allergies has advanced our knowledge of how
environmental factors that influence pathogenic exposures
can hamper the diagnosis of allergy outcomes. Future in-
vestigations must build on our understanding of these links
to generate new tools to diagnose, treat and prevent aller-
gies not only in high income countries but also in the de-
veloping world where allergies are emerging as conditions
of public health importance.
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